Form 4: ADMA Biologics COO Reports Tax Withholding Share Transaction

Kaitlin M. Kestenberg-Messina, COO and SVP of Compliance at ADMA Biologics, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Summary

• On June 30, 2024, Kaitlin M. Kestenberg-Messina, COO and SVP of Compliance at ADMA Biologics, had 2,085 shares of common stock withheld by the issuer to satisfy mandatory tax withholding requirements upon the vesting of restricted stock units (RSUs).
• This was not an open market sale of securities.
• Following the transaction, Kestenberg-Messina beneficially owns 451,590 shares of ADMA Biologics, which includes unvested RSUs and shares of common stock.
• The unvested RSUs were granted on various dates and vest in equal quarterly installments over four years, subject to continued service.
• The 451,590 shares also include 120,520 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing regarding stock transactions, and does not contain information that would significantly impact sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard tax withholding procedure.

Key Dates